Merck Serono Awards Grant for Growth: Deadline approaching

05-Dec-2014 - Germany

Merck Serono reminded that there is just one month remaining for scientists leading innovative research projects to apply for grants as part of the Merck Serono Grant for Growth Innovation (GGI). Grants totalling up to €400,000 will be awarded to one or more selected projects.

Merck Serono is supporting innovative projects that have the potential to advance the understanding of science and medical research in the field of growth. In 2014, the company announced the first recipients of the GGI at the 53rd European Society for Paediatric Endocrinology (ESPE) meeting. The winners were from Sweden, the United Kingdom and the United States.

Steven Hildemann, Global Chief Medical Officer and Head of Global Medical and Safety at Merck Serono said: “Merck Serono has a longstanding and ongoing commitment to advancing the treatment of growth hormone deficiency. The Grant for Growth Innovation demonstrates our support for novel scientific proposals by researchers seeking to accelerate understanding of growth disorders, improve adherence and deliver better outcomes for patients.”

Applications will close on January 6, 2015. For the first application, submissions must contain a letter of intent and a brief description of the research project. The applications will be evaluated by an independent Scientific Steering Committee of internationallyrenowned endocrinologists according to five criteria:

  • Innovation
  • Scientific rationale
  • Clarity
  • Feasibility
  • Impact of research

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances